Related Experiment Videos
Bronchopulmonary dysplasia-oxidative stress and antioxidants
1Department of Pediatric Research, Rikshospitalet, University of Oslo, Norway. o.d.saugstad@klinmed.uion.no
Insights
Oxidative stress significantly contributes to bronchopulmonary dysplasia in preterm infants due to impaired defenses and increased susceptibility. Novel therapies targeting oxidative stress are being explored, but caution is advised with antioxidant supplementation.
Area of Science:
- Neonatal Medicine
- Pulmonary Biology
- Oxidative Stress Research
Background:
- Oxidative stress is increasingly implicated in the pathogenesis of bronchopulmonary dysplasia (BPD).
- Preterm infants are particularly vulnerable due to immature lungs, impaired antioxidant defenses, and increased susceptibility to infection and inflammation.
- Factors like hyperoxia exposure and the presence of free iron exacerbate oxidative stress in neonates.
Purpose of the Study:
- To review the role of oxidative stress in the development of bronchopulmonary dysplasia in newborns.
- To elucidate the molecular and cellular mechanisms underlying free radical-induced injury in this context.
- To discuss potential therapeutic strategies and the challenges associated with antioxidant therapies for BPD.
Main Methods:
- Literature review and synthesis of existing research on oxidative stress and BPD.
- Analysis of factors contributing to increased oxidative stress in preterm infants.
- Examination of molecular pathways involved in oxidative stress-induced cellular damage.
Main Results:
- Oxidative stress plays a critical role in triggering apoptosis and modulating signal transduction pathways relevant to BPD.
- Impaired antioxidant capacity and increased exposure to reactive oxygen species are key contributors in preterm infants.
- Free iron is identified as a catalyst for reactive oxygen species production in this vulnerable population.
Conclusions:
- Understanding the mechanisms of oxidative stress provides a basis for developing novel therapies for BPD.
- Current antioxidant therapies have not yielded significant breakthroughs, and caution is necessary due to potential effects on growth and development.
- Further research is needed to optimize antioxidant strategies for preterm infants at risk of BPD.
Abstract:
There is increasing evidence that oxidative stress is implicated in the development of bronchopulmonary dysplasia. Several important factors contribute to augmented oxidative stress in the newborn and especially the preterm infant: first, because of its immaturity, the lung of preterm infants is frequently exposed to oxygen therapy and hyperoxia. Second, the antioxidant defense and its ability to be induced during an hyperoxic challenge are impaired. Third, the preterm infant has an increased susceptibility to infection and inflammation, which increases oxidative stress. Fourth, free iron, which catalyzes the production of toxic reactive oxygen species, can be detected in preterm infants. The molecular and cellular mechanisms for free radical-induced injury are now understood in more detail, and it is clear that oxidative stress plays an important role in triggering apoptosis, in serving as second messenger and in signal transduction. This new insight might lead to novel and efficient therapies. So far, there has been no significant breakthrough regarding antioxidant therapies. Care should, however, be exercised in supplementing the preterm infant with antioxidants since this may affect growth and development.